Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
925K
-
Shares change
-
+308K
-
Total reported value, excl. options
-
$5.37M
-
Value change
-
+$2.5M
-
Number of buys
-
12
-
Number of sells
-
-4
-
Price
-
$5.81
Significant Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q4 2020
21 filings reported holding SLS - SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 925K shares
of 107M outstanding shares and own 0.87% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (577K shares), BlackRock Inc. (100K shares), Equitable Holdings, Inc. (94.3K shares), GEODE CAPITAL MANAGEMENT, LLC (34.4K shares), Virtu Financial LLC (19.4K shares), JANE STREET GROUP, LLC (19.4K shares), NORTHERN TRUST CORP (16.2K shares), Bank of New York Mellon Corp (16.1K shares), DIMENSIONAL FUND ADVISORS LP (15.4K shares), and Engineers Gate Manager LP (14.6K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.